Completed
Extracorporeal Phototherapy with Oral Methoxsalen for Epidermolysis Bullosa Acquisita
What is being tested
methoxsalen
Drug
Who is being recruted
Congenital Abnormalities+11
+ Congenital, Hereditary, and Neonatal Diseases and Abnormalities
+ Pathologic Processes
Over 18 Years
How is the trial designed
Treatment Study
Phase 2
Interventional
Study Start: February 1996
Summary
Principal SponsorNational Center for Research Resources (NCRR)
Last updated: June 24, 2005
Sourced from a government-validated database.Claim as a partner
Study start date: February 1, 1996
Actual date on which the first participant was enrolled.PROTOCOL OUTLINE: Oral methoxsalen (8-MOP) is administered 90 minutes prior to leukapheresis. Blood mononuclear cells are exposed to ultraviolet A light for 3 hours, then returned to the patient. The process is repeated on 2 successive days. Patients are re-treated every 3 to 4 weeks for a total of 6 treatments or until the skin has cleared.
Principal SponsorNational Center for Research Resources (NCRR)
Last updated: June 24, 2005
Sourced from a government-validated database.Claim as a partner
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.Design Details
10 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Treatment Study
These studies test new ways to treat a disease, condition, or health issue. The goal is to see if a new drug, therapy, or approach works better or has fewer side effects than existing options.
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Conditions
Criteria
Any sex
Biological sex of participants that are eligible to enroll.Over 18 Years
Range of ages for which participants are eligible to join.Healthy volunteers not allowed
If individuals who are healthy and do not have the condition being studied can participate.Conditions
Pathology
Congenital AbnormalitiesCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesPathologic ProcessesSkin AbnormalitiesSkin Diseases, VesiculobullousSkin Diseases, GeneticPathological Conditions, Signs and SymptomsSkin and Connective Tissue DiseasesDisease AttributesEpidermolysis BullosaSkin DiseasesEpidermolysis Bullosa AcquisitaGenetic Diseases, InbornRare Diseases
Criteria
Active epidermolysis bullosa acquisita
Study Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has no location dataSave this study to your profile to know when the location data is available.
CompletedNo study centers